Barclays
GH icon

Barclays’s Guardant Health GH Stock Holding History

Barclays’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50,100
Closed -$3.84M – 7043
2019
Q1 		$3.84M Buy
+50,100
New +$2.78M ﹤0.01% 1894

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Barclays's GH Position: Q2 2026 in Review

Barclays reduced its Guardant Health (GH) stake by 40% in Q2 2026, selling an estimated $11.2M and leaving 151,204 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Barclays first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $34.3M in Q4 2025. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Barclays held 151,204 shares of Guardant Health worth $22.7M as of Q2 2026.
  • Barclays sold 102,755 Guardant Health shares in Q2 2026, an estimated $11.2M.
  • Guardant Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1067 holding.
  • Barclays first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
  • Barclays's Guardant Health position peaked at $34.3M in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.